Stryker

What Stryker does

Stryker Corporation, founded in 1941 and headquartered in Kalamazoo, Michigan, is a publicly traded (NYSE: SYK) global medical technology company operating across orthopaedics, neurotechnology, and medical-surgical equipment. Its portfolio spans the Mako SmartRobotics platform for robotic-assisted hip, knee, and shoulder replacement, orthopaedic implants and instruments (Trident II, Pangea, Gamma4, TPX HD power tools), neurosurgical and neurovascular devices (BrainPath, Myriad SPECTRA, Cerus Endovascular, AXS Vecta 46), surgical visualization (1688 AIM camera systems, blue light cystoscopy), acute care equipment (ProCuity beds, LIFEPAK defibrillators, Vocera communications), and AI-enabled applications (Triton blood-loss monitoring). The company also sells modular OR wall systems and a growing range of acquired technologies spanning breast cancer localization (MOLLI Surgical), sports medicine soft tissue fixation (Artelon), and peripheral vascular (Amplitude Vascular, Inari Medical). Revenue is generated primarily through hardware sales of medical devices and implants, complemented by services, training, software, and multi-year enterprise contracts.

The company reaches customers through direct enterprise field sales across regional subsidiaries in more than 50 countries, supplemented by group purchasing organization (GPO) agreements and regional distributors. Its primary customer segments are hospitals, health systems, and ambulatory surgery centers performing orthopaedic, neuro, and acute care procedures, with additional reach into emergency medical services and office-based specialists. Pricing is negotiated bilaterally and through GPO contracts rather than publicly disclosed, and Stryker supports adoption through structured surgeon training programs and reference centers in key growth markets such as India and the United States.

Stryker's commercial engine is amplified by a sustained acquisition program that has integrated more than fifteen companies since 2018, including Wright Medical ($4B), Vocera ($3.09B), K2M ($1.4B), NICO Corporation, MOLLI Surgical, mfPHD, SERF SAS, Amplitude Vascular Systems ($835M), and the pending Inari Medical transaction ($4.8B). Leadership is headed by Chairman and CEO Kevin Lobo, with Spencer Stiles appointed President and COO effective January 1, 2026, and Andy Pierce leading MedSurg and Neurotechnology. The company employs approximately 56,000 people globally, reported $25.1B in 2025 revenue, and is valued at roughly $117B by market capitalization with a Q1 2026 quarterly run-rate of $6.02B.

Name

Stryker

Legal name

Stryker Corporation

Website

http://www.stryker.com/en-us/index.htm

Company type

Public

Founded year

1941

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Stryker is a global medical technology company that designs, manufactures, and sells orthopaedic implants, robotic-assisted surgery systems (Mako), neurosurgical and neurovascular devices, surgical visualization, and acute care equipment to hospitals, ambulatory surgery centers, and emergency care providers across more than 50 countries.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)

akta.pro secondary industries

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF), Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Orthopaedic medical devices
• Surgical robotics systems
• Neurotechnology products
• Medical imaging equipment
• Patient care solutions

Headquarters

HQ city

Kalamazoo

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical and Surgical Equipment: Stryker generates revenue primarily through the sale of medical and surgical equipment including hospital beds, stretchers, patient handling systems, surgical visualization systems (cameras, endoscopes, cystoscopes), temperature management, and other acute care equipment. Products are sold directly to healthcare providers and through distribution channels globally.
2. Orthopaedic Implants and Instruments: Revenue from joint replacement implants (hip, knee, shoulder), trauma devices (nails, plates, screws), sports medicine products, spine implants, and associated surgical instruments. Includes Mako robotic-assisted procedures and related consumables.
3. Neurotechnology Products: Revenue from neurosurgical equipment, neurovascular devices, craniomaxillofacial products, and interventional spine solutions. Includes products from acquisitions such as NICO Corporation (BrainPath, Myriad SPECTRA) and Cerus Endovascular.
4. Services and Solutions: Revenue from service contracts, maintenance, training and education programs, and software solutions including navigation systems, connected OR platforms, and digital health integrations.
5. Dividend Distributions: Stryker declared a quarterly dividend of $0.88 per share (4.8% increase from prior year), payable to shareholders, reflecting shareholder return practices.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Stryker manufactures and sells a broad portfolio of medical technology products including orthopaedic implants and instruments (joint replacements, trauma devices, sports medicine), the Mako SmartRobotics platform for robotic-assisted surgery, neurotechnology products (neurosurgical, neurovascular, spine), medical and surgical equipment (endoscopy cameras, hospital beds, defibrillators, waste management), and AI-enabled platforms such as Triton blood loss monitoring. These products are sold primarily to hospitals, ambulatory surgery centers (ASCs), and healthcare providers through direct enterprise field sales and distribution channels globally.

Product overview

Stryker is a global medical technology company offering a comprehensive portfolio organized into three main segments: Orthopaedics and Spine (including Mako SmartRobotics for robotic-assisted joint replacement, trauma systems like Gamma4 and T2 nails, Pangea Plating System, Trident II Acetabular System, and foot/ankle solutions), Neurotechnology (including neurosurgical, neurovascular, spine, and craniomaxillofacial products, blue light cystoscopy for bladder cancer detection), and Medical and Surgical Equipment (including endoscopy camera systems like 1688 AIM and 1588 AIM, Vocera communication platform, Sage patient care products, Neptune waste management systems, hospital beds, and emergency care devices). The company has pursued an active acquisition strategy, adding products like the Triton AI blood loss monitoring platform (from Gauss Surgical), BrainPath and Myriad SPECTRA neurosurgical technologies (from NICO Corporation), MOLLI 2 wire-free localization system (from MOLLI Surgical), and modular OR wall systems (from mfPHD). Stryker serves healthcare providers across acute care, ambulatory surgery centers, and office-based settings, impacting over 150 million patients annually.

Differentiator

Problem solved

Functional benefit

Brands

• Mako: Robotic-arm assisted surgery platform for joint replacement procedures
• Triton
• Sage
• BrainPath
• Vocera
• Pangea Plating System
• Trident II Acetabular System
• TPX HD

Products and services

• Mako SmartRobotics Robotic-assisted surgery platform for hip, knee, and shoulder replacement procedures. Combines 3D planning software with robotic arm assistance to enable patient-specific surgical planning and real-time intraoperative guidance for orthopaedic surgeons.
• TPX HD Power Tool Premium small bone power tool designed for demanding orthopaedic procedures such as total joint revisions, minimally invasive surgery, and oral maxillofacial procedures. Delivers up to 296% more torque than TPX Micro Drill with customizable control.
• Pangea Plating System Plating platform for treating a wide range of fracture patterns in extremities. Developed in collaboration with 26 orthopaedic surgeons worldwide and incorporates global anatomical data with variable-angle plating capabilities.
• Trident II Acetabular System Advanced hip replacement solution for total hip arthroplasty incorporating additive manufactured Tritanium In-Growth Technology and X3 highly crosslinked polyethylene, compatible with the Mako SmartRobotics platform.
• Triton Blood Loss Monitoring Platform AI-enabled platform using computer vision for real-time surgical blood loss monitoring, enabling early hemorrhage detection and improved maternal health outcomes. FDA-cleared.
• BrainPath Minimally invasive neurosurgical access technology for brain tumor removal and stroke care procedures.
• Myriad SPECTRA Minimally invasive neurosurgical technology for brain tumor removal procedures.
• MOLLI 2 Localization System Wire-free soft tissue localization technology for breast-conserving surgery, enabling precise targeting of cancerous tissue during breast cancer procedures.
• Vocera Communication Platform Clinical communication and care coordination technology enabling healthcare teams to address challenges across the continuum of care.
• 1688 AIM Camera System 4K advanced imaging camera platform with multiple modalities for various surgical specialties including orthopaedics, gynecology, colorectal, general surgery, ENT, and urology.
• Stryker ENT Navigation System (Scopis) Next-generation navigation system for functional endoscopic sinus surgery (FESS) offering advanced image guidance and visualization capabilities with augmented reality technology.
• Blue Light Cystoscope Bladder cancer detection technology using blue light cystoscopy that makes cancer cells glow bright pink under ultraviolet light, identifying up to 25% more bladder cancers than conventional white light cystoscopy.
• ProCuity Hospital Bed System Hospital bed system for acute care settings.
• LIFEPAK Defibrillators and Emergency Care Products Emergency response devices including LIFEPAK defibrillators, POWER-PRO stretchers, and HeartSine samaritan PAD for public access defibrillation.
• Gamma4 Hip Fracture Nail System Cephalomedullary nail system for treating intertrochanteric fractures, proximal femur fractures, and associated femoral shaft fractures, available in short, intermediate, and long sizes.
• T2 Femur A/R Intramedullary Nail Antegrade/retrograde intramedullary nail system for treatment of diaphyseal femur fractures and distal femur fractures.
• T2 Alpha Femur GT Nail GT femur nail system for antegrade femur procedures including treatment of fractures, pseudoarthrosis, malunions, and pathological fractures.
• Hoffmann LRF External Fixation System External fixation system for treatment of open and closed fractures, post-traumatic contracture, pseudoarthrosis, limb lengthening, bone transport, and foot reconstruction.
• Neptune Waste Management Systems Surgical smoke and fluid waste management systems for operating rooms, including Neptune 3 waste management system and Neptune SafeAir smoke evacuation pencil.
• Sage Patient Care Products Oral hygiene and patient care products including antiseptic body cleansing washcloths, heel protectors, oral hygiene systems, and TAP 2.0 for patient care.
• AXS Vecta 46 Intermediate Catheter Intermediate catheter for mechanical thrombectomy in acute ischemic stroke treatment.

Quantifiable outcome

• Stryker impacts over 150 million patients annually through its products and partnerships
• +3 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability3 records

Feature10 records

Partnerships

14 partnerships are on record, tiered minor and core.

• Shane Lowry (Professional Golfer)minorGTM or Marketing Partner · 24 June 2026Stryker named professional golfer Shane Lowry as a sponsored brand ambassador for its Joint Replacement division. The global campaign includes media, social channels, and educational initiatives aimed at raising awareness about joint pain treatment and elevating the role of caregivers in the recovery journey. Lowry intends to share his personal experience as a caregiver to his father, who received knee and hip replacements. The partnership includes Stryker branding appearing on Lowry's kit from the Travelers Championship onwards.
• Amplitude Vascular Systems (AVS)coreStrategic or Co-development Partner · 19 May 2026Stryker agreed to acquire Amplitude Vascular Systems for up to $835 million, representing a landmark pre-FDA exit for the Michigan-based medical technology startup. AVS developed a next-generation hydraulic intravascular lithotripsy platform (Pulse System) for treating calcified peripheral arterial disease, using CO2-generated pressure waves delivered through a balloon catheter. The acquisition expands Stryker's peripheral vascular portfolio and is expected to close in Q2 2026.
• Inari MedicalcoreStrategic or Co-development Partner · 15 May 2026Stryker announced its intention to acquire Inari Medical in a multibillion-dollar cash deal valued at approximately $4.8 billion. Inari Medical develops thrombectomy systems for the treatment of venous thromboembolism and other blood flow conditions. The acquisition was announced amid Inari's robust quarterly revenue growth driven by its thrombectomy systems and is expected to significantly expand Stryker's position in vascular disease treatment.
• Max Smart Super Speciality Hospital, Saket (India)coreStrategic or Co-development Partner · 13 May 2026Stryker and Max Smart Super Speciality Hospital, Saket announced a strategic collaboration to establish the hospital as a training and education center for robotic-arm assisted joint replacement in India. The partnership aims to address India's growing burden of arthritis and joint disorders by developing clinical expertise and improving access to technology-enabled orthopaedic treatments through structured surgeon training frameworks. The initiative aligns with India's broader healthcare priorities of innovation, skilling, and quality care while supporting Stryker's commitment to scaling robotics-assisted surgical capabilities across Asia Pacific.
• NICO CorporationcoreStrategic or Co-development Partner · 20 September 2024Stryker completed the acquisition of NICO Corporation, a company specializing in minimally invasive neurosurgical technologies for brain tumor removal and stroke care. The acquisition includes NICO's BrainPath and Myriad SPECTRA products, which facilitate brain tumor removal procedures. The strategic move aims to improve surgical outcomes and expand Stryker's presence in neurosurgical solutions.
• MOLLI SurgicalcoreStrategic or Co-development Partner · 31 July 2024Stryker completed the acquisition of MOLLI Surgical, a company specializing in wire-free soft tissue localization technology for breast-conserving surgery. MOLLI's products include the MOLLI 2 localization system and OncoPen, which aid surgeons in precisely targeting cancerous tissue during breast cancer surgeries. The acquisition enhances Stryker's portfolio in breast cancer surgical solutions and is part of its strategy to improve patient care through innovation.
• ArteloncoreStrategic or Co-development Partner · 3 June 2024Stryker announced a definitive agreement to acquire Artelon, a private company specializing in soft tissue fixation products for foot, ankle, and sports medicine procedures. The acquisition aims to strengthen Stryker's product range and competitive positioning with innovative biomaterial technology in the foot and ankle and sports medicine segments. Both companies operated separately until closing.
• mfPHDcoreStrategic or Co-development Partner · 30 April 2024Stryker completed the acquisition of mfPHD, a provider of modular stainless steel wall systems for hospitals and ambulatory surgery centers, located in Flower Mound, Texas. The deal allows Stryker to expand its offerings in modular operating room design and develop an ecosystem of embedded technologies for intelligent operating rooms.
• SERF SAScoreStrategic or Co-development Partner · 21 March 2024Stryker completed the acquisition of SERF SAS, a France-based joint replacement company, from Menix. The acquisition enhances Stryker's global orthopaedic portfolio and its presence in Europe, strengthening its position in the joint replacement market.
• Cerus EndovascularcoreStrategic or Co-development Partner · 2 May 2023Stryker completed its acquisition of Cerus Endovascular, a strategic move to expand Stryker's portfolio in the medical device sector, specifically in neurovascular and interventional technologies.
• Gauss SurgicalcoreStrategic or Co-development Partner · 7 September 2021Stryker completed its acquisition of Gauss Surgical, a medical device company based in Menlo Park, CA, that developed the Triton platform using artificial intelligence for real-time blood loss monitoring during surgery. The technology aims to improve maternal health outcomes by enabling early hemorrhage detection and has received FDA clearance.
• Epworth Geelong (Australia)minorStrategic or Co-development PartnerEpworth Geelong in Australia became the first hospital in the country to install Stryker's blue light cystoscope technology for bladder cancer detection, performing its first procedure in April 2026. The technology makes cancer cells glow bright pink under ultraviolet light, enabling identification of up to 25% more bladder cancers than conventional white light cystoscopy.
• UPMC Sports Surgery Clinic (Dublin, Ireland)minorStrategic or Co-development PartnerUPMC Sports Surgery Clinic in Dublin, Ireland completed the first European procedure using Stryker's Mako Shoulder robotic-assisted platform for shoulder replacement surgery, performed by Dr. Ruth Delaney. The system combines Blueprint 3D planning software with Stryker shoulder implants and Mako SmartRobotics technology to enable patient-specific surgical planning and real-time intraoperative guidance.
• Sai Bhaskar Hospitals (Vijayawada, India)minorStrategic or Co-development PartnerSai Bhaskar Hospitals in Vijayawada announced plans to ensure all joint replacement surgeries are robot-assisted within four years, working with Stryker to implement advanced treatment protocols. The Managing Director emphasized the goal of enhancing precision, safety, and personalized patient care through the adoption of robotic-assisted surgery.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Zimmer Biomet: Pure-play orthopaedic competitor with overlapping joint replacement, trauma, and surgical robotics (ROSA) portfolios, competing head-to-head with Stryker's Mako platform.
• Johnson & Johnson (DePuy Synthes): Direct competitor in orthopaedic implants, joint replacement, trauma, and spine through its DePuy Synthes franchise, with comparable global hospital sales infrastructure.
• Smith+Nephew: Competes in orthopaedic reconstruction, sports medicine, and trauma, with the CORI robotic-assisted surgery system directly challenging Mako in joint replacement.
• Globus Medical: Direct spine and orthopaedic competitor, formed via the merger with NuVasive, competing in spinal implants, navigation, and enabling technologies.

Broad incumbents

• Medtronic: Largest diversified medtech company with overlapping portfolios in surgical robotics (Hugo), spine, neurovascular, and surgical instruments. Directly comparable across multiple Stryker segments.
• Boston Scientific: Overlapping portfolio in peripheral vascular, endoscopy, and urology/oncology with Stryker's neurovascular and surgical visualization businesses, frequently cited by analysts as a peer.
• Becton Dickinson: Broad medtech player with overlap in surgical instruments, endoscopy, and acute care equipment, comparable to Stryker's Medical and Surgical Equipment segment.

Emerging players

• Intuitive Surgical: Leader in robotic-assisted surgery with da Vinci platform; increasingly competing in orthopaedic and spine-adjacent applications and setting industry expectations for surgical robotics.
• Inari Medical: Acquisition target of Stryker (~$4.8B) specializing in venous thrombectomy, directly comparable to Stryker's expanding peripheral vascular portfolio.
• Penumbra: Competes in neurovascular thrombectomy and peripheral vascular interventions, overlapping with Stryker's neurovascular and newly acquired Amplitude Vascular portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/user/stryker
• Facebookfacebook.com/strykercareers
• LinkedInlinkedin.com/company/stryker
• Instagraminstagram.com/strykercareers?igshid=1wcmnukna7ee7
• Xx.com/Stryker_Jobs

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A62 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stryker